Eric Langer

is president and managing partner of BioPlan Associates.

Outsourcing is weighing in more as a tactic for cost-cutting, but it is still not the primary weapon.

Outsourcing is weighing in more as a tactic for cost-cutting, but it is still not the primary weapon.

A recent study shows growth in outsourcing of insect- and plant-cell-based bioproduction expression systems.

Growth is seen in outsourcing of insect- and plant-cell-based bioproduction expression systems.

Will international biomanufacturing outsourcing become mainstream in this decade?

Innovation resulting in improved productivity continues unabated and is a primary driver for many of the current biopharmaceutical trends.

Will international biomanufacturing outsourcing become mainstream in this decade?

Budgets for biopharmaceutical activities are gaining in select functional areas except outsourcing.

Budgets for biopharmaceutical activities are gaining in select functional areas except outsourcing.